Structural Biology & Molecular Modeling Techniques Market Analysis & Forecast by End-User 2023 - 2034 (Revenue USD Bn) Structural Biology & Molecular Modeling Techniques Market Analysis & Forecast by ...

Drugs developed by Alphabet’s drug discovery subsidiary and designed by artificial intelligence are expected to head to trial by the end of the year, according to a Google (GOOGL) executive.

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

We recently compiled a list of the 10 AI News You Should Not Miss. In this article, we are going to take a look at where ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.

Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this ...

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Simply sign up to the Artificial intelligence myFT Digest -- delivered directly to your inbox. Isomorphic Labs, the four-year-old drug discovery start-up owned by Google parent Alphabet, will have an ...